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Abstract
Depletion of membrane cholesterol and substitution of endogenous cholesterol with its structural
analogues was used to analyze the mechanism by which cholesterol regulates volume-regulated anion
current (VRAC) in endothelial cells. Depletion of membrane cholesterol enhanced the development of
VRAC activated in a swelling-independent way by dialyzing the cells either with GTPγS or with low ionic
strength solution. Using MβCD–sterol complexes, 50–80% of endogenous cholesterol was substituted
with a specific analogue, as verified by gas-liquid chromatography. The effects of cholesterol depletion
were reversed by the substitution of endogenous cholesterol with its chiral analogue, epicholesterol, or
with a plant sterol, β-sitosterol, two analogues that mimic the effect of cholesterol on the physical
properties of the membrane bilayer. Alternatively, when cholesterol was substituted with coprostanol that
has only minimal effect on the membrane physical properties it resulted in VRAC enhancement, similar to
cholesterol depletion. In summary, our data show that these channels do not discriminate between the
two chiral analogues of cholesterol, as well as between the two cholesterols and β-sitosterol, but
discriminate between cholesterol and coprostanol. These observations suggest that endothelial VRAC is
regulated by the physical properties of the membrane.
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Sensitivity of Volume-regulated Anion Current to
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a b s t r a c t Depletion of membrane cholesterol and substitution of endogenous cholesterol with its structural
analogues was used to analyze the mechanism by which cholesterol regulates volume-regulated anion current
(VRAC) in endothelial cells. Depletion of membrane cholesterol enhanced the development of VRAC activated in
a swelling-independent way by dialyzing the cells either with GTPS or with low ionic strength solution. Using
MCD–sterol complexes, 50–80% of endogenous cholesterol was substituted with a specific analogue, as verified
by gas-liquid chromatography. The effects of cholesterol depletion were reversed by the substitution of endogenous cholesterol with its chiral analogue, epicholesterol, or with a plant sterol, -sitosterol, two analogues that
mimic the effect of cholesterol on the physical properties of the membrane bilayer. Alternatively, when cholesterol
was substituted with coprostanol that has only minimal effect on the membrane physical properties it resulted in
VRAC enhancement, similar to cholesterol depletion. In summary, our data show that these channels do not discriminate between the two chiral analogues of cholesterol, as well as between the two cholesterols and -sitosterol,
but discriminate between cholesterol and coprostanol. These observations suggest that endothelial VRAC is regulated by the physical properties of the membrane.
k e y wor ds : Cl channels • cholesterol analogues • physical properties of the membrane • cell swelling • vascular endothelial cells
I N T R O D U C T I O N

Changes in the level of cellular cholesterol are known
to affect numerous membrane proteins, including several types of ion channels (e.g., Bolotina et al., 1989;
Barrantes, 1993; Chang et al., 1995; Lundbaek et al.,
1996; Romanenko et al., 2002b). Two general mechanisms have been proposed for the regulation of membrane proteins by cholesterol: (a) changing the physical properties of the membrane or (b) direct binding
between cholesterol and the proteins (for reviews see
Barrantes, 1993; Bastiaanse et al., 1997; Burger et al.,
2000). The basis for the first mechanism is a wellknown observation that an increase in membrane cholesterol restricts the motion of phospholipids, resulting
in lipid ordering (e.g., Demel et al., 1972; Stockton and
Smith, 1976), decrease in membrane fluidity (e.g., Brulet and McConnell, 1976; Cooper, 1978; Xu and London, 2000), and increase in membrane stiffness (Evans
and Needham, 1987; Needham and Nunn, 1990). The
latter was proposed to increase membrane deformation
energy altering the energetic cost of the transitions between the conformational states of the ion channels
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(Lundbaek et al., 1996). This hypothesis is supported
by the studies showing that in model membranes, increase in spontaneous monolayer curvature and thickness of the membrane bilayer, factors that are among
the determinants of the membrane deformation energy (Huang, 1986; Nielsen et al., 1998), affect open
probability of antibiotic ion channels, gramicidin
(Lundbaek et al., 1997), and alamethicin (Keller et al.,
1993), and of bacterial mechanosensitive MscL channels (Perozo et al., 2002). There is little evidence, however, for the regulation of mammalian anion channels
by cholesterol-induced changes in the physical properties of the membrane bilayer in living cells.
We focus on endothelial volume–regulated Cl current, a key process in cell volume homeostasis (for review see Nilius et al., 1996) that is also implicated in the
regulation of cell cycle (Shen et al., 2000), cell proliferation (Manolopoulos et al., 1997; Voets et al., 1997),
and angiogenesis (Manolopoulos et al., 2000). In addition, more recent studies show that VRAC is sensitive to
mechanical fluid shear stress (Barakat et al., 1999; Romanenko et al., 2002a), suggesting that it may contrib-

Abbreviations used in this paper: BAEC, bovine aortic endothelial cell;
GTPS, guanosine 5-O-(3-thiotriphosphate); MCD, methyl--cyclodextrin; VRAC, volume-regulated anion current; i, intracellular
ionic strength.
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ute to shear stress-induced regulation of the endothelium. Our earlier study has shown that VRAC is inversely dependent on the level of cellular cholesterol
(Levitan et al., 2000). The first goal of this study is to
determine whether the effect of cholesterol on VRAC
may be accounted for by altering the mechanical constraint to cell swelling that is due to cytoskeleton. This
possibility has to be considered because cholesterol depletion has been shown to release several cytoskeletal
proteins, such as actin, -actinin, and ezrin, from the
cellular membrane fractions (Harder et al., 1997), suggesting that it may uncouple the membrane from the
underlying cytoskeleton and, consequently, decrease
cell stiffness and allow cells to swell more. In this study,
however, we show that cholesterol depletion enhances
VRAC in a swelling-independent way.
The second question addressed in this study is
whether the sensitivity of VRAC to cholesterol is due to
cholesterol-induced changes in the physical properties
of the membrane bilayer or due to specific sterol–protein interactions defined as direct binding between
cholesterol and the channel protein or a modulatory
protein. Development of -cyclodextrin–cholesterol
donor/acceptor system that allows precise adjustment
of the level of cellular cholesterol to different levels
(Christian et al., 1997) and the substitution of cholesterol with its structural analogues (Gimpl et al., 1997)
has provided strong tools to discriminate between the
specific and nonspecific effects of cholesterol. In our
recent study, we have shown that this method can be
used to substitute 50% of endogenous cholesterol
with its chiral isomer epicholesterol in intact vascular
endothelial cells without apparent cell damage (Romanenko et al., 2002b). Here, we extend this approach
to demonstrate a strong correlation between the effects
of cholesterol structural analogues on VRAC and their
known effects on the physical properties of the membrane lipid bilayer providing the first evidence that
VRAC is regulated by membrane physical properties.
M A T E R I A L S

A N D

M E T H O D S

Modulation of Cellular Cholesterol Level and Substitution of
Cholesterol with Sterol Analogues
Bovine aortic endothelial cells (BAECs) between passages 10
and 30 were grown in DMEM (Cell Grow) supplemented with
10% FBS (GIBCO BRL). BAECs were enriched with or depleted
of cholesterol by incubating them with methyl- -cyclodextrin
(MCD) saturated with cholesterol or with empty M CD (not
complexed with cholesterol), as described previously (Levitan et
al., 2000). Briefly, a small volume of cholesterol stock solution in
chloroform:methanol (1:1, vol:vol) was added to a glass tube and
the solvent was evaporated. Then, 2.5 or 5 mM M CD solution in
DMEM medium without serum was added to the dried cholesterol. The tube was vortexed, sonicated, and incubated overnight
in a shaking bath at 37C. MCD was saturated with cholesterol
at an MCD:cholesterol molar ratio of 8:1, the saturation limit of
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TABLE I

Levels of Sterols in BAECs Treated with M CD and
MCD-cholesterol Complexes
Conditions
5 mM MCD, 2 h

Cholesterol, g/mg protein
7.45

0.45

2.5 mM MCD, 1 h

14.91

0.96

Control

22.62

2.02

2.5 mM MCD-cholesterol, 1 h

31.92

2.16

5 mM MCD-cholesterol, 2 h

46.44

1.46

Cholesterol levels in BAECs exposed to MCD and MCD-cholesterol
complexes for indicated periods and in control cells measured by GLC
(n 8–12).

MCD (Christian et al., 1997). In preparation for an experiment,
cells were washed three times with serum-free DMEM to remove
the serum from the growth medium. Cells were then incubated
with MCD saturated solution or with MCD solution containing
no cholesterol (empty MCD) for 60 or 120 min. During the incubation, cells were maintained in a humidified CO2 incubator
at 37C. Control cells were treated similarly and incubated with
serum-free DMEM solution without any M CD. After exposure
to MCD, cells were washed three times with serum-free medium
and returned to the incubator. After treatment, cells were kept in
serum-free medium and were found to maintain the elevated or
the decreased level of cholesterol for at least 48 h, providing the
time window for the electrophysiological recordings (Table I).
Analogous procedure was used for substitution of membrane
cholesterol with epicholesterol, -sitosterol, and coprostanol using respective analogue instead of cholesterol for preparation of
MCD–sterol complex. MCD and sterols were purchased from
Sigma-Aldrich or Steraloids.

Measurement of Cellular Sterols
Quantitative analysis of membrane cholesterol and epicholesterol was done as described previously (Romanenko et al.,
2002b). Briefly, total lipid was extracted from the cell monolayers
using isopropanol with addition of known amount of cholesteryl
methyl ether (CME) as an internal standard. The extracts were
dried in the flow of N2 at 35C, reextracted with chlorophorm:
methanol:water system (Bligh and Dyer, 1959), dissolved in CS2,
and analyzed by gas-liquid chromatography (GLC) as described
previously (Ishikawa et al., 1974; Klansek et al., 1995). Cell protein was determined on the lipid-extracted monolayer using a
modification (Markwell et al., 1978) of the method of Lowry
(Lowry et al., 1951). All mass values were normalized on the basis
of cell protein. Quantifications of membrane -sitosterol and coprostanol were performed using the same procedure.

Electrophysiological Recording
Ionic currents were measured using the whole-cell and outside-out
excised patch configurations (Hamill et al., 1981). Pipettes were
pulled (SG10 glass; Richland Glass) to give a final resistance of 2–6
M . A saturated salt agar bridge was used as the reference electrode. Currents were recorded using an EPC9 amplifier (HEKA
Electronik) and accompanying acquisition and analysis software
(Pulse & PulseFit; HEKA Electronik). Whole-cell capacitance and
series resistance were compensated and monitored throughout
the recording. Whole-cell currents were elicited by 500-ms linear
voltage ramps from 60 to 60 mV with an interpulse interval of
5 s The holding potential between the ramps was 60 mV. Excised
patches were pulled from the cells after full VRAC development
and single channel current was recorded using a voltage-step pro-
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tocol, as described previously by (Jackson and Strange, 1995). Single-channel recordings were done with a 50- s sampling interval
and filtered at 500 Hz. The external recording solution contained
(in mM): 150 NaCl, 1 EGTA, 2 CaCl2, 10 HEPES, pH 7.3. The basic internal solution contained (in mM): 120 or 140 Cs-Glutamate,
10 HEPES, 4 ATP, pH 7.3 (CsOH), with free [Ca2 ] 10 nM (0.1
CaCl2, 1.1 EGTA). VRAC was activated by either supplementing
the internal solution with 100 M GTPS or by lowering the concentration of Cs-Glutamate to 90 mM. The osmolarities of all solutions were determined immediately before recording with a vapor
pressure osmometer (Wescor, Inc.) and were adjusted by the addition of sucrose, as required. All chemicals for the recording solutions were obtained from Fisher Scientific or Sigma-Aldrich. Only
cells that retained normal morphology after the M CD treatments
were taken for the analysis.

Analysis
Ionic strength (i) was calculated as: i
1/2 mizi2, half the
sum of the molalities of each ion in the solution (m i) multiplied
by the square of its charge (zi) (Moore, 1972). It was approximated that zwitterions of HEPES and glutamate contribute to
ionic strength of the solutions as monoanionic acids with pKa 7.6
and 4.3, respectively. 120 Cs-Glutamate, 10 HEPES, 0.1 CaCl 2, 1.1
EGTA, 4 ATP, pH 7.3 (CsOH) has ionic strength 0.133 (  was
1.039 0.002 kg/l). Analogous solutions with 90 or 140 mM CsGlutamate have ionic strengths of 0.104 and 0.153, respectively
( were 1.041 0.004 kg/l and 1.036 0.002 kg/l, respectively).
The calculations were performed using WINMAX v2.40 software
(Bers et al., 1994).
Activation rates of VRAC were calculated as maximal slopes of
the linear regression of the time-courses of the current increase
normalized by the peak amplitude of the current and maximal
current densities were calculated by normalizing peak VRAC currents by the cell capacitance. Analysis of the single-channel properties was performed using TAC software (Bruxton). Statistical
analysis of the data was performed using a standard two-sample
Student’s t test and was considered significant if two-tailed P values were 0.05. All values are presented as means SE.
R E S U L T S

Cholesterol Depletion Enhances VRAC in the Absence of
Osmotic Stress
Two strategies were employed in this study to activate
VRAC in the absence of osmotic stress: (a) dialyzing the
cells with guanosine 5-O-(3-thiotriphosphate) (GTPS)
(Doroshenko et al., 1991; Nilius et al., 1999; Estevez et
al., 2001), and (b) a decrease in the intracellular ionic
strength (i) (Nilius et al., 1998; Voets et al., 1999; Sabirov et al., 2000). To test the sensitivity of GTP Sinduced and I-induced VRAC to the level of cellular
cholesterol, the cells were exposed to “empty” MCD for
2 h resulting in removal of 70% of cellular cholesterol
(Fig. 1 A). Intracellular dialysis of the cells with GTPS
(100 M) induced transient development of VRAC
(Fig. 1 B), consistent with the earlier studies (Doroshenko et al., 1991; Nilius et al., 1999; Estevez et al.,
2001). Depletion of cellular cholesterol resulted in a
significant increase in current density (Fig. 1, B and C),
indicating that the effect of cholesterol can occur in the
absence of cell swelling and it cannot be accounted for
79
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by an increase in cell swelling. The rate of current activation was not affected by cholesterol depletion.
To test whether the observed effect may be due to the
effect of cholesterol depletion on the unitary conductance of VRAC channels, single-channel events were recorded in excised outside-out configurations after the
current has developed (Fig. 1 D). After the excision,
single-channel events can be observed under strong
depolarization that induces channel closing. In most
cases, when the channels close they stay closed for a
prolonged period of time (Fig. 1 D, a), but in some
cases the channels may flicker between the open and
closed states for a short period of time before they close
completely (Fig. 1 D, b). The amplitudes of the singlechannels events were indistinguishable in cells depleted of cholesterol and in control cells (Fig. 1 E).
In our previous study we have shown that swellingactivated VRAC becomes insensitive to changes in the
membrane cholesterol level when activated by strong
osmotic gradient, indicating the maximal number of
swelling-activated channels is not altered by changes in
the membrane cholesterol (Levitan et al., 2000). Here
we also tested whether the effect of cholesterol depletion on GTPS-induced VRAC is different at low and at
saturating levels of GTPS. VRAC currents were recorded in BAECs dialyzed with increasing concentration of GTPS (Fig. 2 A). The figure shows that at 50–
100 M GTPS VRAC reached an apparent maximum.
To confirm that at 100 M GTPS the current indeed
reaches the maximal value, average maximal current
densities were compared at 100 M and 2 mM GTPS
concentrations when recorded the same day and were
found virtually indistinguishable (P
0.96, n
13–
15). Fig. 2 B shows that the effect of cholesterol depletion on VRAC activated at low GTPS concentration is
similar to that at saturating GTPS concentration.
Similarly to GTPS-activated VRAC, cholesterol
depletion significantly enhanced VRAC development
when the current was activated by decreasing the intracellular ionic strength (Fig. 3 A and B). The intracellular ionic strength was reduced by dialyzing the cells
with low salt solution (i 104 mM) where the solution
was adjusted with sucrose to maintain normal osmolarity (310 mOsM). Furthermore, cholesterol depletion
alone was sufficient to induce spontaneous VRAC activity (Fig. 3, C and D). When dialyzed with isosmotic intracellular solution with i 153 mM, control cells develop only a low-amplitude, nonselective cation current
and virtually no VRAC (Levitan and Garber, 1998). In
contrast, cells depleted of cholesterol show clear VRAC
development (Fig. 3 C) with the maximal current density in cholesterol depleted cells being 4 times higher
than the baseline current density (Fig. 3 D).
To analyze further the quantitative relationship between GTPS-induced and low i -induced VRAC and

Figure 1. Effect of cholesterol depletion on
whole-cell and single-channel VRAC induced by
GTPS. (A) Cholesterol levels in BAECs exposed
to 5 mM MCD and in control cells measured by
GLC (n 8–12; *P  0.01). (B) Typical families
of current traces recorded from individual cells
dialyzed with 100 M GTPS elicited by application of linear voltage ramps materials and
methods. The time-courses of VRAC current
densities that developed in the same cells calculated by normalizing the maximal current amplitudes ( 60 mV) of each individual ramp by the
cell capacitance. (C) The activation rates and
mean peak current densities of VRAC in cells
treated with MCD or control cells (n 11–19).
(D) Single-channel currents recorded in the outside-out excised patch configuration after a depolarization step from 60 to 140 mV. Examples
of recordings when the channels were closing for
a prolonged period of time (a) and the channels
that flickered between the open and closed states
(b). (E) Unitary conductances of the channels recorded in the membranes of the cells depleted of
cholesterol and control cells.

cellular cholesterol, the level of cellular cholesterol was
titrated by exposing the cells to either 2.5 or 5 mM
MCD or MCD–cholesterol complex. The level of
free cholesterol was measured for every experimental
condition and, as expected, the efficiency of cholesterol depletion/enrichment was proportional to MCD
concentration. Fig. 4 shows maximal current densities
of GTPS-induced and low i-induced VRAC plotted as
a function of free cellular cholesterol. The functional
dependence of both GTPS-induced and low  i induced VRAC current densities on cellular-free cholesterol was fitted with a single exponential (correlation
coefficients of 0.99 for both GTPS-induced and for
low i-induced VRAC). While it is remarkable that the
quantitative dependences of GTPS-induced and iinduced VRAC on the level of cellular cholesterol are
virtually identical, they differ from the cholesterol dependence of swelling-induced VRAC. The main difference is that swelling-induced VRAC was sensitive to high
levels of cholesterol (Levitan et al., 2000). These observations suggest that cholesterol may affect VRAC devel80

opment by more than one mechanism and while
GTPS- and i-induced VRAC retains its sensitivity to
the low levels of cholesterol, it loses the component
that is sensitive to the high level of cellular cholesterol.
VRAC Development Is Not Sensitive to the Substitution of
Cholesterol by Epicholesterol
As described in our previous study (Romanenko et al.,
2002b), exposing the cells to 2.5 mM MCD saturated
with epicholesterol resulted in removal of 50% of endogenous cholesterol, which was substituted with the
similar amount of epicholesterol during the same exposure (Fig. 5 A). The effect of cholesterol/epicholesterol
substitution on VRAC development was tested for both
GTPS-induced and low i-induced currents (Fig. 5, B
and D, respectively). Our observations show that substitution of 50% of endogenous cholesterol with epicholesterol had no significant effect on either GTPSinduced or low i-induced VRAC, indicating that the
channels are insensitive to the chirality of the cholesterol isomer in the membrane (Fig. 5, C and D). In-
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Figure 2. Effect of cholesterol depletion is conserved
when VRAC is induced by
various concentrations of
GTPS. (A) Peak current
densities of VRAC were measured in control cells (n
5–13). (B) The mean peak
current densities of VRAC in
cells treated with MCD or
control cells (n 5–13).

Substitution of Endogenous Cholesterol with -sitosterol has a
Small Effect on VRAC Activity
To verify further that VRAC activity is regulated by the
physical properties of the membrane bilayer but not by
specific cholesterol–protein interactions, we have substituted endogenous cholesterol with a plant sterol, -sitosterol that, similarly to the two chiral forms of cholesterol, decreases membrane fluidity (Gimpl et al., 1997)
and induces formation of the structural lipid domains
(Xu and London, 2000). As with cholesterol/epicholesterol substitution, we have optimized the conditions of
the exposure so that 50% of endogenous cholesterol
was substituted with the appropriate amount of -sitos-

Figure 3.
Cholesterol depletion
up-regulates low i-induced VRAC
and induces VRAC activation at high
i. (A and C) Typical families of current traces and time courses recorded in cholesterol-depleted and
control cells dialyzed with solution
with either i
104 mM (A) i
153 mM (C). (B and D) The activation rates and the mean peak current densities in cells dialyzed with
either low or high i solutions, respectively (n 3–10).
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deed, when VRAC activity in MCD-epicholesterol–
treated cells was plotted as a function of total cellular
sterol level it fell exactly on the same exponential curve
that was obtained by titrating the levels of cellular cholesterol (Fig. 9). The equivalent result was observed
when cells, depleted of cholesterol by exposing them to
empty MCD, were reloaded with epicholesterol by exposing them to MCD complexed with epicholesterol.
After the reloading, VRAC current density returned to
the control level. Since the sensitivities of GTPS- and
i-induced VRAC to both cholesterol depletion and to
the substitution of cholesterol with epicholesterol appear to be very similar, the rest of the substitution experiments were performed only for GTPS-induced VRAC.

Substitution of Endogenous Cholesterol with its Analogues has
No Effect on VRAC Unitary Conductance
Similarly to cholesterol depletion, we tested whether
partial substitution of cellular cholesterol with epicholesterol, -sitosterol, or coprostanol affects the unitary conductance of VRAC channels (Fig. 8). We have
found that the amplitudes of the single-channel events
were indistinguishable in cells at all four conditions.
Dependence of VRAC on Total Sterol Level Versus
Cholesterol Alone

Figure 4. Functional dependence of GTPS-induced (A) and low
i-induced (B) VRAC on the level of cellular cholesterol. Peak current densities were measured in cells treated with 5 mM or 2.5 mM
MCD or MCD saturated with cholesterol. The curves were fit to a
single exponent with correlation coefficients of 0.99 (n 8–15).

terol. We have found, however, that cholesterol/-sitosterol substitution invariably resulted in some decrease in
the total sterol level. Typically the level of total sterol was
decreased by 20% (Fig. 6 A). The reason for this partial
depletion effect is probably based on the relative affinities of MCD and of the membrane to the particular sterol. The level of VRAC current density in -sitosterol–
treated cells was slightly but not significantly higher than
in control cells (Fig. 6, B and C). This increase, however,
is accounted for by the decrease in the total sterol level in
these cells, which is apparent from plotting VRAC current density as a function of the total sterol level for different experimental conditions (Fig. 9).
Effect of Cholesterol/coprostanol Substitution Is Similar to that
of Cholesterol Depletion
Finally, we have substituted endogenous cholesterol
with coprostanol that, in contrast to cholesterol, has
only minimal effect on fluidity of the membrane (Gimpl
et al., 1997; Xu and London, 2000). Coprostanol partitioned easily into the membrane resulting in 70% cholesterol/coprostanol substitution with no change in total sterol level (Fig. 7 A). Under these experimental
conditions, VRAC activity was strongly facilitated (Fig.
7, B and C) and was almost identical to the current in
cholesterol-depleted cells (Fig. 9).
82

Fig. 9 summarizes the findings of this study by showing
maximal VRAC amplitudes in different substitution experiments as a function of total cellular sterol (Fig. 9 A)
or as a function of cholesterol alone (Fig. 9 B). The figure shows that when cholesterol is substituted with epicholesterol or with -sitosterol, VRAC current density is
identical to the value predicted from the VRAC/total
sterol curve but when cholesterol is substituted with coprostanol the level of VRAC current density is significantly higher than that predicted by the VRAC/total
sterol curve. In contrast, if VRAC is plotted as a function of cholesterol alone, the picture reverses. When
cholesterol is substituted with coprostanol, VRAC current density is identical to the value predicted by the
VRAC/cholesterol curve, whereas when cholesterol is
substituted with epicholesterol or -sitosterol, it falls
significantly lower than the predicted value. These observations lead to the conclusion that VRAC is regulated by the physical properties of the membrane bilayer and not by specific sterol–protein interactions.
D I S C U S S I O N

The role of cholesterol in regulation of VRAC development was studied by analyzing the sensitivity of VRAC
to changes in the cellular level of cholesterol and to
substitution of endogenous cholesterol with its structural analogues. The main findings of this study are: (a)
cholesterol depletion enhances VRAC activity in a
swelling-independent way, (b) VRAC unitary conductance is not affected by changes in the membrane sterol composition, and (c) VRAC is insensitive to the substitution of cholesterol with the sterols whose effects on
membrane fluidity were shown to be similar to that of
cholesterol, but is strongly affected by the substitution
of cholesterol with a sterol whose effect on membrane
fluidity is similar to that of cholesterol depletion.
The fundamental question for understanding the
mechanisms by which cholesterol affects the function of
membrane proteins is whether cholesterol regulates protein function by specific sterol–protein interactions (direct binding to the protein of interest or to a modulatory
protein) or by changing the physical properties of the
lipid environment. Three experimental approaches are
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Figure 5. Substitution of cholesterol with epicholesterol has no effect on GTPS- and low iinduced VRAC. (A) Structure of epicholesterol
(note  conformation of 3-OH group), GLC profile of the lipid extract of epicholesterol-treated
cells [the peaks are of internal standard (CME)
(a), epicholesterol (b) and cholesterol (c)], and
the concentrations of cholesterol (lighter portion
of the bar) and epicholesterol (darker portion)
measured in cells treated with 2.5 mM MCD saturated with epicholesterol and in control cells
(n 8–9). (B and D) Typical families of current
traces and VRAC time courses in cells treated with
2.5 mM MCD saturated with epicholesterol and
in a control cell recorded upon activation of
VRAC with GTPS (B) and low i (C). (C and E)
The activation rates and the peak current densities in cells exposed to MCD-epicholesterol and
in control cells for both in GTPS- and i-induced
VRAC (n 6–52).

commonly used to test the effect of cholesterol on membrane proteins in living cells. The first approach is depleting the cells of or enriching them with cholesterol by
exposing the cells to cyclodextrins, water-soluble cyclic
carbohydrates with high specificity for cholesterol (e.g.,
Klein et al., 1995; Christian et al., 1997; Gimpl et al.,
1997). As expected, cholesterol removal increases membrane fluidity (Gimpl et al., 1997) and decreases lipid ordering (Gidwani et al., 2001) but altering the level of
cholesterol alone cannot discriminate between the two
mechanisms because both the amount of cholesterol
and the physical properties of the membrane are altered
at the same time. Another approach is to sequester cholesterol with a polyene antibiotic filipin (e.g., (Gimpl et
al., 1997; Scanlon et al., 2001; Mitter et al., 2003)). This
treatment, however, decreases the local concentration of
cholesterol and, therefore, bears the same limitations
as cholesterol depletion. Finally, membrane cholesterol
can be modified by its enzymatic degradation with cholesterol oxidase (e.g., Gimpl et al., 1997; Pang et al.,
1999; Scanlon et al., 2001). This method has the advan83
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tage of preserving membrane fluidity (Gimpl et al.,
1997); however, it tests only the impact of one specific
modification of cholesterol structure. In this study, we
use an alternative approach of quantitative substitution
of endogenous cholesterol by its structural analogues.
This approach is based on application of cyclodextrin
that was first used to titrate cellular cholesterol to different levels (Klein et al., 1995; Christian et al., 1997) and
then developed further to introduce various sterols into
membrane vesicles (Gimpl et al., 1997).
In this study, we substitute endogenous cellular cholesterol with three of its structural analogues: the cholesterol synthetic chiral analogue epicholesterol, the
plant sterol -sitosterol, and coprostanol. Comparing
effects of cholesterol and epicholesterol is the most
commonly used method to discriminate between specific and nonspecific effects of cholesterol on protein
function (Mickus et al., 1992; Gimpl et al., 1997; Sooksaware and Simmonds, 2001). Indeed, cholesterol and
epicholesterol are known to reside at significantly different angles in the membrane (Murari et al., 1986)

Figure 6. Substitution of cholesterol with -sitosterol has no significant effect on GTPS-induced VRAC. (A) Structure of -sitosterol (note the additional ethyl group at position 24), GLC profile
of the lipid extract of -sitosterol-treated cells [(a) CME, (b) cholesterol, and (c) -sitosterol], and the concentrations of cholesterol (lighter portion of the bar) and of -sitosterol (darker portion) measured in cells treated with 5 mM MCD saturated with
-sitosterol and in control cells (n 6). (B) Typical families of current traces and the time-courses of GTPS-induced VRAC recorded in a -sitosterol–treated cell and in control cell. (C) The
peak current densities in treated cells were not significantly different than in control cells (n 13–21).
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Figure 7. Substitution of cholesterol with coprostanol significantly enhances GTPS-induced VRAC. (A) Structure of coprostanol (note the reduced 5 double bond), GLC profile of the lipid
extract of 1 mM MCD-coprostanol treated cells [(a) CME, (b) coprostanol, and (c) cholesterol], and the concentrations of the sterols cholesterol (lighter portion of the bar) and coprostanol
(darker portion) (n
3). (B) Typical families of current traces
and VRAC time-courses of GTPS-induced VRAC in a coprostanoltreated cell and in a control cell. (C) The peak current densities
(n 21–23; *P  0.01).
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Figure 9. Functional dependence of GTPS-induced VRAC on
the level of total sterol (A) and on the level of endogenous cholesterol (B) in sterol substitution experiments. (A) The mean peak
current densities plotted as a function of total sterol level in cells
treated with MCD or MCD saturated with cholesterol (), in
the cells treated with MCD saturated with epicholesterol (),
in the cells treated with MCD saturated with sitosterol (), and
in the cells treated with MCD saturated with coprostanol (). All
the values were normalized by their respective values in control
cells. (B) The graph represents the same set of data as in A, plotted as a function of cellular cholesterol alone.

Figure 8. Substitution of cholesterol with its analogues does not
affect unitary conductance of GTPS-induced VRAC. (A) Examples of single-channel currents recorded in the outside-out excised
patch configuration after a depolarization step from 60 to 140
mV. (B) Unitary conductances of the channels recorded in the
membranes of the cells substituted with cholesterol analogues and
control cells (n 3–5).
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and therefore are expected to differ in direct binding
to membrane proteins. In addition, cholesterol was
substituted with -sitosterol, which incorporates a structural modification at the opposite end of the cholesterol molecule than epicholesterol but, similarly to epicholesterol, is known to have an effect on membrane
fluidity indistinguishable from that of cholesterol. Coprostanol, on the other hand, was chosen because its effect is similar to that of cholesterol depletion. Effects of
these sterols on the physical properties of the membrane were measured both in simple reconstituted
lipid systems (Xu and London, 2000) and in membrane vesicles isolated from epithelial cells HEK293
(Gimpl et al., 1997; Xu and London, 2000). The effects
of the sterols on membrane fluidity in membrane vesicles are very similar to their effects in reconstituted
lipid systems suggesting that these observations reflect
general effects of the sterols on membrane properties.
Our study shows that the effects of the three analogues
on VRAC correlate closely to their effects on the physical properties of the membrane. Therefore, while it is
not feasible to completely exclude the possibility that

the sterols regulate VRAC by directly binding to the
channel because the molecular nature of VRAC is not
yet identified, our current observations suggest that
physical properties of the membrane play an important
role in the regulation of VRAC activity.
What are the molecular mechanisms that may be responsible for the regulation of membrane proteins by
the physical properties of the membrane? First, since the
unitary conductance of VRAC is not affected, we can exclude the possibility that sterols affect VRAC pore properties. We also show that the effect of cholesterol depletion is not abolished at the saturating levels of GTPS,
indicating that cholesterol does not affect the GTPSdependent transition between the closed and the open
states. If the effect is abolished, as we have demonstrated
earlier for swelling-activated VRAC (Levitan et al., 2000),
then it strongly suggests that it is not due to an increase
in the number of the channels. If, however, the effect is
not abolished at the saturating level of the stimulus, as is
the case for GTPS-sensitive VRAC, it suggests that cholesterol affects the transition that is not dependent on
GTPS and the simplest explanation is that cholesterol
alters the distribution between the population of closed
unavailable channels and the joint population of closed
but available and open channels.
On a mechanistic level, one possibility is that cholesterol affects the distribution between different conformational states of the channels, as was proposed by the
membrane deformation model. Specifically, the model
suggests that changes in the lipid composition of the
membrane that affect the structural stress of the membrane are expected to alter the energetic cost of the
transition between the open and the closed states of
the channels (Lundbaek and Andersen, 1994; Lundbaek et al., 1996). Indeed, sterols that increase the ordering of phospholipids (cholesterol, epicholesterol,
and -sitosterol) also inhibit the current, whereas cholesterol depletion that has a disordering effect on the
membrane (Gidwani et al., 2001) as well as substitution
of membrane cholesterol with an analogue, which does
not increase ordering (Xu and London, 2000), facilitate channel activity. The correlation of the sterol effects on the transition between the nonavailable and
the available channels with the change in bilayer physical properties suggests that this regulation involves a
change in the cost of bilayer deformation. Another possible mechanism that may be responsible for the sensitivity of volume-regulated anion channels to cholesterol is segregation of the proteins into cholesterol-rich
domains (lipid rafts). Organization of the lipid rafts
is driven by lipid–lipid, protein–lipid, and protein–
protein interactions (Lai, 2003), and these domains
may serve as scaffolds for protein–protein interactions (Brown and London, 1998; Simons and Toomre,
2000). The two mechanisms are distinct but not mutu86

ally exclusive because segregation into a raft may affect
channel function by altering its lipid environment.
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